Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Documentation
Home
>
Investors & media
>
Documentation
Year
All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Documentation type
All
General Assembly
Financial statements and reports
Regulated information
Corporate presentations
General meetings
28 April 2026
General meetings
Statutory auditors’ report on the issuance of share subscription warrants (BSA), subscription and/or acquisition warrants for new and/or existing shares (BSAANE), and/or redeemable subscription and/or acquisition warrants for new and/or existing shares (BSAAR), with cancellation of preferential subscription rights (FR)
Open in new window
28 April 2026
General meetings
Statutory auditors’ report on the issuance of shares and various securities with maintenance and/or cancellation of preferential subscription rights (FR)
Open in new window
28 April 2026
General meetings
Statutory auditors’ report on the capital reduction (FR)
Open in new window
28 April 2026
General meetings
Statutory auditors’ certificate on the information provided pursuant to Article L. 225-115 4° of the French Commercial Code relating to the total amount of remuneration paid to the highest-paid individuals for the financial year ended December 31, 2025 (FR)
Open in new window
16 April 2026
General Assembly, General meetings
Shares and voting rights statement – 2026 General Meeting
Open in new window
16 April 2026
General meetings
Notice of the 2026 General Meeting
Open in new window
15 April 2026
Financial statements and reports, General Assembly, Regulated information
URD 2025
Open in new window
10 March 2026
Regulated information
ANNEX IX MARCH 2026
Open in new window
01 February 2026
Regulated information
H2 2025 Liquidity Contract Report
Open in new window
29 January 2026
Investor newsletter
INVESTOR NEWSLETTER – JANUARY 2026 (ENGLISH)
Open in new window
View previous 9 articles
1
2
3
4
5
6
7
…
27
View next 9 articles
Go back to the page of the page